DXVX Soars on First License-Out DealNature Cell[K-Bio Pulse] 유진희 2025.07.31 오전 09:00 Sellbion CEO Kwon Kim: “Maximizing the Power of 177Lu-DGUL Immuno-Oncology Combo” 유진희 2025.07.21 오전 09:30 Wonik Soars on Policy Tailwinds; Y2Solution Gains on Licensing Buzz[K-Bio Pulse] 유진희 2025.06.05 오전 09:10 AdBiotech Rallies on Biotech Breakthrough Hopes[K-Bio Pulse] 유진희 2025.06.11 오전 08:11 AdBiotech and HK Inno.N Surge on Future Value Hopes[K-Bio Pulse] 유진희 2025.06.10 오전 08:12 Cellbion Starts Merck Trial, Targets Global Sales and Licensing 유진희 2025.06.05 오전 10:53 로딩중..